Global Legionella Testing
Global Legionella Testing

Legionella Testing Comprehensive Study by Type (Microbial Culture, DFA Stain, PCR, Others), Application (Water Testing, IVD Testing), End User (Hospital and Clinic, Diagnostic Laboratory) Players and Region - Global Market Outlook to 2026

Legionella Testing Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 237 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Legionella Testing Market Scope?
Legionella is a type of bacteria that can cause a serious form of pneumonia called Legionnaires disease. A legionella infection affects the lower respiratory tract, often requires hospitalization, and has a significant mortality rate. In addition to pneumonia, Legionella bacteria can also cause Pontiac fever, a milder and self-limiting illness with flu-like symptoms (without pneumonia). Together, Legionnaires disease and Pontiac fever are referred to as legionellosis. Legionella testing detects the presence of the bacteria or parts of it (antigens) to help diagnose the cause of a person's pneumonia.

The Legionella Testing market study is being classified by Type (Microbial Culture, DFA Stain, PCR and Others), by Application (Water Testing and IVD Testing) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Legionella Testing market throughout the predicted period.

Beckman Coulter (United States), Bio-Rad Laboratories (United States), Abbott (United States), Roche Diagnostics (Switzerland), Thermo Fischer Scientific(United States), Becton, Dickinson (BD) (United States), BioMerieux(France), Eiken Chemical(Japan), Hologic (United States) and Pro-lab Diagnostics(United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are QIAGEN (United States) and Takara Bio(Japan).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Legionella Testing market by Type, Application and Region.

On the basis of geography, the market of Legionella Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Technological Advancements in the Field of Bacterial Testing

Market Drivers
  • Pneumonia and Legionella-related illnesses are becoming more common
  • Rapid and Advanced Diagnostic Techniques are in High Demand

Opportunities
  • Increasing spending on the healthcare system in developing regions

Restraints
  • Concern about the sensitivity of diagnostic tests

Challenges
  • Insufficient Disposable Income


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Legionella Testing Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Frequently Asked Questions (FAQ):

1. At what growth rate would the Legionella Testing market expands?
The Global Legionella Testing market is expected to see a growth of % during projected year 2020 to 2026.

2. Who are the prominent players of the Global Legionella Testing market?
The prominent players of Global Legionella Testing market are Beckman Coulter (United States), Bio-Rad Laboratories (United States), Abbott (United States), Roche Diagnostics (Switzerland), Thermo Fischer Scientific(United States), Becton, Dickinson (BD) (United States), BioMerieux(France), Eiken Chemical(Japan), Hologic (United States) and Pro-lab Diagnostics(United States), to name a few.

3. What are the top priorities to focus for Legionella Testing marketís growth?
In this highly competitive & fast evolving Legionella Testing industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.
Report Objectives / Segmentation Covered
By Type
  • Microbial Culture
  • DFA Stain
  • PCR
  • Others
By Application
  • Water Testing
  • IVD Testing
By End User
  • Hospital and Clinic
  • Diagnostic Laboratory

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Pneumonia and Legionella-related illnesses are becoming more common
      • 3.2.2. Rapid and Advanced Diagnostic Techniques are in High Demand
    • 3.3. Market Challenges
      • 3.3.1. Insufficient Disposable Income
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Field of Bacterial Testing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Legionella Testing, by Type, Application, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Legionella Testing (Value)
      • 5.2.1. Global Legionella Testing by: Type (Value)
        • 5.2.1.1. Microbial Culture
        • 5.2.1.2. DFA Stain
        • 5.2.1.3. PCR
        • 5.2.1.4. Others
      • 5.2.2. Global Legionella Testing by: Application (Value)
        • 5.2.2.1. Water Testing
        • 5.2.2.2. IVD Testing
      • 5.2.3. Global Legionella Testing by: End User (Value)
        • 5.2.3.1. Hospital and Clinic
        • 5.2.3.2. Diagnostic Laboratory
      • 5.2.4. Global Legionella Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Legionella Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Beckman Coulter (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Roche Diagnostics (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fischer Scientific(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton, Dickinson (BD) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMerieux(France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eiken Chemical(Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hologic (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pro-lab Diagnostics(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Legionella Testing Sale, by Type, Application, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Legionella Testing (Value)
      • 7.2.1. Global Legionella Testing by: Type (Value)
        • 7.2.1.1. Microbial Culture
        • 7.2.1.2. DFA Stain
        • 7.2.1.3. PCR
        • 7.2.1.4. Others
      • 7.2.2. Global Legionella Testing by: Application (Value)
        • 7.2.2.1. Water Testing
        • 7.2.2.2. IVD Testing
      • 7.2.3. Global Legionella Testing by: End User (Value)
        • 7.2.3.1. Hospital and Clinic
        • 7.2.3.2. Diagnostic Laboratory
      • 7.2.4. Global Legionella Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Legionella Testing: by Type(USD Million)
  • Table 2. Legionella Testing Microbial Culture , by Region USD Million (2015-2020)
  • Table 3. Legionella Testing DFA Stain , by Region USD Million (2015-2020)
  • Table 4. Legionella Testing PCR , by Region USD Million (2015-2020)
  • Table 5. Legionella Testing Others , by Region USD Million (2015-2020)
  • Table 6. Legionella Testing: by Application(USD Million)
  • Table 7. Legionella Testing Water Testing , by Region USD Million (2015-2020)
  • Table 8. Legionella Testing IVD Testing , by Region USD Million (2015-2020)
  • Table 9. Legionella Testing: by End User(USD Million)
  • Table 10. Legionella Testing Hospital and Clinic , by Region USD Million (2015-2020)
  • Table 11. Legionella Testing Diagnostic Laboratory , by Region USD Million (2015-2020)
  • Table 12. South America Legionella Testing, by Country USD Million (2015-2020)
  • Table 13. South America Legionella Testing, by Type USD Million (2015-2020)
  • Table 14. South America Legionella Testing, by Application USD Million (2015-2020)
  • Table 15. South America Legionella Testing, by End User USD Million (2015-2020)
  • Table 16. Brazil Legionella Testing, by Type USD Million (2015-2020)
  • Table 17. Brazil Legionella Testing, by Application USD Million (2015-2020)
  • Table 18. Brazil Legionella Testing, by End User USD Million (2015-2020)
  • Table 19. Argentina Legionella Testing, by Type USD Million (2015-2020)
  • Table 20. Argentina Legionella Testing, by Application USD Million (2015-2020)
  • Table 21. Argentina Legionella Testing, by End User USD Million (2015-2020)
  • Table 22. Rest of South America Legionella Testing, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Legionella Testing, by Application USD Million (2015-2020)
  • Table 24. Rest of South America Legionella Testing, by End User USD Million (2015-2020)
  • Table 25. Asia Pacific Legionella Testing, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Legionella Testing, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Legionella Testing, by Application USD Million (2015-2020)
  • Table 28. Asia Pacific Legionella Testing, by End User USD Million (2015-2020)
  • Table 29. China Legionella Testing, by Type USD Million (2015-2020)
  • Table 30. China Legionella Testing, by Application USD Million (2015-2020)
  • Table 31. China Legionella Testing, by End User USD Million (2015-2020)
  • Table 32. Japan Legionella Testing, by Type USD Million (2015-2020)
  • Table 33. Japan Legionella Testing, by Application USD Million (2015-2020)
  • Table 34. Japan Legionella Testing, by End User USD Million (2015-2020)
  • Table 35. India Legionella Testing, by Type USD Million (2015-2020)
  • Table 36. India Legionella Testing, by Application USD Million (2015-2020)
  • Table 37. India Legionella Testing, by End User USD Million (2015-2020)
  • Table 38. South Korea Legionella Testing, by Type USD Million (2015-2020)
  • Table 39. South Korea Legionella Testing, by Application USD Million (2015-2020)
  • Table 40. South Korea Legionella Testing, by End User USD Million (2015-2020)
  • Table 41. Taiwan Legionella Testing, by Type USD Million (2015-2020)
  • Table 42. Taiwan Legionella Testing, by Application USD Million (2015-2020)
  • Table 43. Taiwan Legionella Testing, by End User USD Million (2015-2020)
  • Table 44. Australia Legionella Testing, by Type USD Million (2015-2020)
  • Table 45. Australia Legionella Testing, by Application USD Million (2015-2020)
  • Table 46. Australia Legionella Testing, by End User USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Legionella Testing, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Legionella Testing, by Application USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Legionella Testing, by End User USD Million (2015-2020)
  • Table 50. Europe Legionella Testing, by Country USD Million (2015-2020)
  • Table 51. Europe Legionella Testing, by Type USD Million (2015-2020)
  • Table 52. Europe Legionella Testing, by Application USD Million (2015-2020)
  • Table 53. Europe Legionella Testing, by End User USD Million (2015-2020)
  • Table 54. Germany Legionella Testing, by Type USD Million (2015-2020)
  • Table 55. Germany Legionella Testing, by Application USD Million (2015-2020)
  • Table 56. Germany Legionella Testing, by End User USD Million (2015-2020)
  • Table 57. France Legionella Testing, by Type USD Million (2015-2020)
  • Table 58. France Legionella Testing, by Application USD Million (2015-2020)
  • Table 59. France Legionella Testing, by End User USD Million (2015-2020)
  • Table 60. Italy Legionella Testing, by Type USD Million (2015-2020)
  • Table 61. Italy Legionella Testing, by Application USD Million (2015-2020)
  • Table 62. Italy Legionella Testing, by End User USD Million (2015-2020)
  • Table 63. United Kingdom Legionella Testing, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Legionella Testing, by Application USD Million (2015-2020)
  • Table 65. United Kingdom Legionella Testing, by End User USD Million (2015-2020)
  • Table 66. Netherlands Legionella Testing, by Type USD Million (2015-2020)
  • Table 67. Netherlands Legionella Testing, by Application USD Million (2015-2020)
  • Table 68. Netherlands Legionella Testing, by End User USD Million (2015-2020)
  • Table 69. Rest of Europe Legionella Testing, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Legionella Testing, by Application USD Million (2015-2020)
  • Table 71. Rest of Europe Legionella Testing, by End User USD Million (2015-2020)
  • Table 72. MEA Legionella Testing, by Country USD Million (2015-2020)
  • Table 73. MEA Legionella Testing, by Type USD Million (2015-2020)
  • Table 74. MEA Legionella Testing, by Application USD Million (2015-2020)
  • Table 75. MEA Legionella Testing, by End User USD Million (2015-2020)
  • Table 76. Middle East Legionella Testing, by Type USD Million (2015-2020)
  • Table 77. Middle East Legionella Testing, by Application USD Million (2015-2020)
  • Table 78. Middle East Legionella Testing, by End User USD Million (2015-2020)
  • Table 79. Africa Legionella Testing, by Type USD Million (2015-2020)
  • Table 80. Africa Legionella Testing, by Application USD Million (2015-2020)
  • Table 81. Africa Legionella Testing, by End User USD Million (2015-2020)
  • Table 82. North America Legionella Testing, by Country USD Million (2015-2020)
  • Table 83. North America Legionella Testing, by Type USD Million (2015-2020)
  • Table 84. North America Legionella Testing, by Application USD Million (2015-2020)
  • Table 85. North America Legionella Testing, by End User USD Million (2015-2020)
  • Table 86. United States Legionella Testing, by Type USD Million (2015-2020)
  • Table 87. United States Legionella Testing, by Application USD Million (2015-2020)
  • Table 88. United States Legionella Testing, by End User USD Million (2015-2020)
  • Table 89. Canada Legionella Testing, by Type USD Million (2015-2020)
  • Table 90. Canada Legionella Testing, by Application USD Million (2015-2020)
  • Table 91. Canada Legionella Testing, by End User USD Million (2015-2020)
  • Table 92. Mexico Legionella Testing, by Type USD Million (2015-2020)
  • Table 93. Mexico Legionella Testing, by Application USD Million (2015-2020)
  • Table 94. Mexico Legionella Testing, by End User USD Million (2015-2020)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Legionella Testing: by Type(USD Million)
  • Table 106. Legionella Testing Microbial Culture , by Region USD Million (2021-2026)
  • Table 107. Legionella Testing DFA Stain , by Region USD Million (2021-2026)
  • Table 108. Legionella Testing PCR , by Region USD Million (2021-2026)
  • Table 109. Legionella Testing Others , by Region USD Million (2021-2026)
  • Table 110. Legionella Testing: by Application(USD Million)
  • Table 111. Legionella Testing Water Testing , by Region USD Million (2021-2026)
  • Table 112. Legionella Testing IVD Testing , by Region USD Million (2021-2026)
  • Table 113. Legionella Testing: by End User(USD Million)
  • Table 114. Legionella Testing Hospital and Clinic , by Region USD Million (2021-2026)
  • Table 115. Legionella Testing Diagnostic Laboratory , by Region USD Million (2021-2026)
  • Table 116. South America Legionella Testing, by Country USD Million (2021-2026)
  • Table 117. South America Legionella Testing, by Type USD Million (2021-2026)
  • Table 118. South America Legionella Testing, by Application USD Million (2021-2026)
  • Table 119. South America Legionella Testing, by End User USD Million (2021-2026)
  • Table 120. Brazil Legionella Testing, by Type USD Million (2021-2026)
  • Table 121. Brazil Legionella Testing, by Application USD Million (2021-2026)
  • Table 122. Brazil Legionella Testing, by End User USD Million (2021-2026)
  • Table 123. Argentina Legionella Testing, by Type USD Million (2021-2026)
  • Table 124. Argentina Legionella Testing, by Application USD Million (2021-2026)
  • Table 125. Argentina Legionella Testing, by End User USD Million (2021-2026)
  • Table 126. Rest of South America Legionella Testing, by Type USD Million (2021-2026)
  • Table 127. Rest of South America Legionella Testing, by Application USD Million (2021-2026)
  • Table 128. Rest of South America Legionella Testing, by End User USD Million (2021-2026)
  • Table 129. Asia Pacific Legionella Testing, by Country USD Million (2021-2026)
  • Table 130. Asia Pacific Legionella Testing, by Type USD Million (2021-2026)
  • Table 131. Asia Pacific Legionella Testing, by Application USD Million (2021-2026)
  • Table 132. Asia Pacific Legionella Testing, by End User USD Million (2021-2026)
  • Table 133. China Legionella Testing, by Type USD Million (2021-2026)
  • Table 134. China Legionella Testing, by Application USD Million (2021-2026)
  • Table 135. China Legionella Testing, by End User USD Million (2021-2026)
  • Table 136. Japan Legionella Testing, by Type USD Million (2021-2026)
  • Table 137. Japan Legionella Testing, by Application USD Million (2021-2026)
  • Table 138. Japan Legionella Testing, by End User USD Million (2021-2026)
  • Table 139. India Legionella Testing, by Type USD Million (2021-2026)
  • Table 140. India Legionella Testing, by Application USD Million (2021-2026)
  • Table 141. India Legionella Testing, by End User USD Million (2021-2026)
  • Table 142. South Korea Legionella Testing, by Type USD Million (2021-2026)
  • Table 143. South Korea Legionella Testing, by Application USD Million (2021-2026)
  • Table 144. South Korea Legionella Testing, by End User USD Million (2021-2026)
  • Table 145. Taiwan Legionella Testing, by Type USD Million (2021-2026)
  • Table 146. Taiwan Legionella Testing, by Application USD Million (2021-2026)
  • Table 147. Taiwan Legionella Testing, by End User USD Million (2021-2026)
  • Table 148. Australia Legionella Testing, by Type USD Million (2021-2026)
  • Table 149. Australia Legionella Testing, by Application USD Million (2021-2026)
  • Table 150. Australia Legionella Testing, by End User USD Million (2021-2026)
  • Table 151. Rest of Asia-Pacific Legionella Testing, by Type USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Legionella Testing, by Application USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Legionella Testing, by End User USD Million (2021-2026)
  • Table 154. Europe Legionella Testing, by Country USD Million (2021-2026)
  • Table 155. Europe Legionella Testing, by Type USD Million (2021-2026)
  • Table 156. Europe Legionella Testing, by Application USD Million (2021-2026)
  • Table 157. Europe Legionella Testing, by End User USD Million (2021-2026)
  • Table 158. Germany Legionella Testing, by Type USD Million (2021-2026)
  • Table 159. Germany Legionella Testing, by Application USD Million (2021-2026)
  • Table 160. Germany Legionella Testing, by End User USD Million (2021-2026)
  • Table 161. France Legionella Testing, by Type USD Million (2021-2026)
  • Table 162. France Legionella Testing, by Application USD Million (2021-2026)
  • Table 163. France Legionella Testing, by End User USD Million (2021-2026)
  • Table 164. Italy Legionella Testing, by Type USD Million (2021-2026)
  • Table 165. Italy Legionella Testing, by Application USD Million (2021-2026)
  • Table 166. Italy Legionella Testing, by End User USD Million (2021-2026)
  • Table 167. United Kingdom Legionella Testing, by Type USD Million (2021-2026)
  • Table 168. United Kingdom Legionella Testing, by Application USD Million (2021-2026)
  • Table 169. United Kingdom Legionella Testing, by End User USD Million (2021-2026)
  • Table 170. Netherlands Legionella Testing, by Type USD Million (2021-2026)
  • Table 171. Netherlands Legionella Testing, by Application USD Million (2021-2026)
  • Table 172. Netherlands Legionella Testing, by End User USD Million (2021-2026)
  • Table 173. Rest of Europe Legionella Testing, by Type USD Million (2021-2026)
  • Table 174. Rest of Europe Legionella Testing, by Application USD Million (2021-2026)
  • Table 175. Rest of Europe Legionella Testing, by End User USD Million (2021-2026)
  • Table 176. MEA Legionella Testing, by Country USD Million (2021-2026)
  • Table 177. MEA Legionella Testing, by Type USD Million (2021-2026)
  • Table 178. MEA Legionella Testing, by Application USD Million (2021-2026)
  • Table 179. MEA Legionella Testing, by End User USD Million (2021-2026)
  • Table 180. Middle East Legionella Testing, by Type USD Million (2021-2026)
  • Table 181. Middle East Legionella Testing, by Application USD Million (2021-2026)
  • Table 182. Middle East Legionella Testing, by End User USD Million (2021-2026)
  • Table 183. Africa Legionella Testing, by Type USD Million (2021-2026)
  • Table 184. Africa Legionella Testing, by Application USD Million (2021-2026)
  • Table 185. Africa Legionella Testing, by End User USD Million (2021-2026)
  • Table 186. North America Legionella Testing, by Country USD Million (2021-2026)
  • Table 187. North America Legionella Testing, by Type USD Million (2021-2026)
  • Table 188. North America Legionella Testing, by Application USD Million (2021-2026)
  • Table 189. North America Legionella Testing, by End User USD Million (2021-2026)
  • Table 190. United States Legionella Testing, by Type USD Million (2021-2026)
  • Table 191. United States Legionella Testing, by Application USD Million (2021-2026)
  • Table 192. United States Legionella Testing, by End User USD Million (2021-2026)
  • Table 193. Canada Legionella Testing, by Type USD Million (2021-2026)
  • Table 194. Canada Legionella Testing, by Application USD Million (2021-2026)
  • Table 195. Canada Legionella Testing, by End User USD Million (2021-2026)
  • Table 196. Mexico Legionella Testing, by Type USD Million (2021-2026)
  • Table 197. Mexico Legionella Testing, by Application USD Million (2021-2026)
  • Table 198. Mexico Legionella Testing, by End User USD Million (2021-2026)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Legionella Testing: by Type USD Million (2015-2020)
  • Figure 5. Global Legionella Testing: by Application USD Million (2015-2020)
  • Figure 6. Global Legionella Testing: by End User USD Million (2015-2020)
  • Figure 7. South America Legionella Testing Share (%), by Country
  • Figure 8. Asia Pacific Legionella Testing Share (%), by Country
  • Figure 9. Europe Legionella Testing Share (%), by Country
  • Figure 10. MEA Legionella Testing Share (%), by Country
  • Figure 11. North America Legionella Testing Share (%), by Country
  • Figure 12. Global Legionella Testing share by Players 2020 (%)
  • Figure 13. Global Legionella Testing share by Players (Top 3) 2020(%)
  • Figure 14. Global Legionella Testing share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 17. Beckman Coulter (United States) Revenue: by Geography 2020
  • Figure 18. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bio-Rad Laboratories (United States) Revenue: by Geography 2020
  • Figure 20. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott (United States) Revenue: by Geography 2020
  • Figure 22. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Roche Diagnostics (Switzerland) Revenue: by Geography 2020
  • Figure 24. Thermo Fischer Scientific(United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fischer Scientific(United States) Revenue: by Geography 2020
  • Figure 26. Becton, Dickinson (BD) (United States) Revenue, Net Income and Gross profit
  • Figure 27. Becton, Dickinson (BD) (United States) Revenue: by Geography 2020
  • Figure 28. BioMerieux(France) Revenue, Net Income and Gross profit
  • Figure 29. BioMerieux(France) Revenue: by Geography 2020
  • Figure 30. Eiken Chemical(Japan) Revenue, Net Income and Gross profit
  • Figure 31. Eiken Chemical(Japan) Revenue: by Geography 2020
  • Figure 32. Hologic (United States) Revenue, Net Income and Gross profit
  • Figure 33. Hologic (United States) Revenue: by Geography 2020
  • Figure 34. Pro-lab Diagnostics(United States) Revenue, Net Income and Gross profit
  • Figure 35. Pro-lab Diagnostics(United States) Revenue: by Geography 2020
  • Figure 36. Global Legionella Testing: by Type USD Million (2021-2026)
  • Figure 37. Global Legionella Testing: by Application USD Million (2021-2026)
  • Figure 38. Global Legionella Testing: by End User USD Million (2021-2026)
  • Figure 39. South America Legionella Testing Share (%), by Country
  • Figure 40. Asia Pacific Legionella Testing Share (%), by Country
  • Figure 41. Europe Legionella Testing Share (%), by Country
  • Figure 42. MEA Legionella Testing Share (%), by Country
  • Figure 43. North America Legionella Testing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Beckman Coulter (United States)
  • Bio-Rad Laboratories (United States)
  • Abbott (United States)
  • Roche Diagnostics (Switzerland)
  • Thermo Fischer Scientific(United States)
  • Becton, Dickinson (BD) (United States)
  • BioMerieux(France)
  • Eiken Chemical(Japan)
  • Hologic (United States)
  • Pro-lab Diagnostics(United States)
Additional players considered in the study are as follows:
QIAGEN (United States) , Takara Bio(Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation